Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Cannabis is known to be associated with neuropsychiatric problems, but less is known about complications affecting other specified body systems. We report and analyze 35 recent remarkable cardiovascular complications following cannabis use. Methods and Results: In F rance, serious cases of abuse and dependence in response to the use of psychoactive substances must be reported to the national system of the F rench Addictovigilance Network. We identified all spontaneous reports of cardiovascular complications related to cannabis use collected by the F rench Addictovigilance Network from 2006 to 2010. We described the clinical characteristics of these cases and their evolution: 1.8% of all cannabis‐related reports (35/1979) were cardiovascular complications, with patients being mostly men (85.7%) and of an average age of 34.3 years. There were 22 cardiac complications (20 acute coronary syndromes), 10 peripheral complications (lower limb or juvenile arteriopathies and Buerger‐like diseases), and 3 cerebral complications (acute cerebral angiopathy, transient cortical blindness, and spasm of cerebral artery). In 9 cases, the event led to patient death. Conclusions: Increased reporting of cardiovascular complications related to cannabis and their extreme seriousness (with a death rate of 25.6%) indicate cannabis as a possible risk factor for cardiovascular disease in young adults, in line with previous findings. Given that cannabis is perceived to be harmless by the general public and that legalization of its use is debated, data concerning its danger must be widely disseminated. Practitioners should be aware that cannabis may be a potential triggering factor for cardiovascular complications in young people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Universal Definition of Myocardial Infarction: Clinical Insights
Paiva, L., Providência, R., Barra, S., Dinis, P., Faustino, A. C., & Gonçalves, L. (2015) · Cardiology · doi:10.1159/000371739 · Cited by 2,513
Fox, K. A. A., Dabbous, O. H., Goldberg, R. J., Pieper, K. S., Eagle, K. A., Van de Werf, F., Avezum, Á., Goodman, S. G., Flather, M. D., Anderson, F. A., et al. (2006) · BMJ · doi:10.1136/bmj.38985.646481.55 · Cited by 1,693
European Monitoring Centre for Drugs and Drug Addiction
Anderson, M. (2014) · European Union regulations | European Encyclopedia of law · Cited by 1,213
Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 772
Triggering Myocardial Infarction by Marijuana
Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.23.2805 · Cited by 767
Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012) · BMJ · doi:10.1136/bmj.e536 · Cited by 735
Rumsfeld, J. S., Alexander, K. P., Goff, D. C., Graham, M. M., Ho, P. M., Masoudi, F. A., Moser, D. K., Roger, V. L., Slaughter, M. S., Smolderen, K. G., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182949a2e · Cited by 540
Public health importance of triggers of myocardial infarction: a comparative risk assessment
Nawrot, T. S., Perez, L., Künzli, N., Munters, E., & Nemery, B. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62296-9 · Cited by 518
Nationwide study of sudden cardiac death in persons aged 1–35 years
Winkel, B. G., Holst, A. G., Theilade, J., Kristensen, I. B., Thomsen, J. L., Ottesen, G. L., Bundgaard, H., Svendsen, J. H., Haunsø, S., & Tfelt-Hansen, J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq428 · Cited by 390
Westover, A. N., McBride, S., & Haley, R. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.495 · Cited by 324
Cardiovascular System Effects of Marijuana
Jones, R. T. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06004.x · Cited by 319
Thomas, G., Kloner, R. A., & Rezkalla, S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.042 · Cited by 302
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Mir, A., Obafemi, A., Young, A., & Kane, C. (2011) · Pediatrics · doi:10.1542/peds.2010-3823 · Cited by 266
Cardiovascular Consequences of Marijuana Use
Sidney, S. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06005.x · Cited by 242
Marijuana Use, Diet, Body Mass Index, and Cardiovascular Risk Factors (from the CARDIA Study)
Rodondi, N., Pletcher, M. J., Liu, K., Hulley, S. B., & Sidney, S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.024 · Cited by 199
O’Sullivan, S. E., Tarling, E. J., Bennett, A. J., Kendall, D. A., & Randall, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.121 · Cited by 184
Rates of Spontaneous Reporting of Adverse Drug Reactions in France
Bégaud, B., Martin, K., Haramburu, F., & Moore, N. (2002) · JAMA · doi:10.1001/jama.288.13.1588 · Cited by 178
Editor's Note: The Process Addictions and the New ASAM Definition of Addiction
Smith, D. E. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662105 · Cited by 147
Cannabis-related Stroke: Myth or Reality?
Wolff, V., Armspach, J., Lauer, V., Rouyer, O., Bataillard, M., Marescaux, C., & Gény, B. (2012) · Stroke · doi:10.1161/strokeaha.112.671347 · Cited by 143
Chronic toxicology of cannabis
Reece, A. S. (2009) · Clinical Toxicology · doi:10.1080/15563650903074507 · Cited by 138
Wells, D. L., & Ott, C. A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p580 · Cited by 117
Kuepper, R., Morrison, P. D., van Os, J., Murray, R. M., Kenis, G., & Henquet, C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.031 · Cited by 116
Cannabis‐related hospitalizations: unexpected serious events identified through hospital databases
Jouanjus, E., Leymarie, F., Tubery, M., & Lapeyre‐Mestre, M. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03897.x · Cited by 112
Self-citationThe histopathology of drugs of abuse
Milroy, C. M., & Parai, J. L. (2011) · Histopathology · doi:10.1111/j.1365-2559.2010.03728.x · Cited by 102
Effect of smoking marihuana and of a high‐nicotine cigarette on angina pectoris
Aronow, W. S., & Cassidy, J. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975175549 · Cited by 90
Stevens, J., Erber, E., Truesdale, K. P., Wang, C., & Cai, J. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws461 · Cited by 65
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 60
Cannabis Arteritis: Review of the Literature
Cottencin, O., Karila, L., Lambert, M., Arveiller, C., Benyamina, A., Boissonas, A., Goudemand, M., & Reynaud, M. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181beb022 · Cited by 54
Interactions between specific parameters of cannabis use and verbal memory
Wagner, D. R., Becker, B., Gouzoulis‐Mayfrank, E., & Daumann, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.004 · Cited by 53
Mallaina, P., Lionis, C. D., Rol, H., Imperiali, R., Burgess, A., Nixon, M., & Malvestiti, F. M. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-362 · Cited by 52
Wu, L.-T. T., Parrott, A. C., Ringwalt, C. L., Yang, C., & Blazer, D. G. (2009) · American Journal on Addictions · doi:10.3109/10550490903206049 · Cited by 47
Assessment and management of cannabis use disorders in primary care
WINSTOCK, A. R., Ford, C., & Witton, J. (2010) · BMJ · doi:10.1136/bmj.c1571 · Cited by 45
Jouanjus, É., Pourcel, L., Saivin, S., Molinier, L., & Lapeyre‐Mestre, M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3280 · Cited by 39
Self-citationWagner, A., Arveiler, D., Ruidavets, J. B., Bingham, A., Montaye, M., Ferrières, J., Dallongeville, J., Haas, B., & Ducimetière, P. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312452967 · Cited by 36
Methods for Clinical Research Involving Cannabis Administration
Gorelick, D. A., & Heishman, S. J. (2006) · Humana Press eBooks · doi:10.1385/1-59259-999-0:235 · Cited by 22
Cited by
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 439
Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31789-1 · Cited by 357
Evaluating the public health impacts of legalizing recreational cannabis use in the United States
Hall, W., & Lynskey, M. (2016) · Addiction · doi:10.1111/add.13428 · Cited by 357
Assessing the public health impacts of legalizing recreational cannabis use: the US experience
Hall, W., & Lynskey, M. (2020) · World Psychiatry · doi:10.1002/wps.20735 · Cited by 296
Metadata
- Authors
- Jouanjus, E., Lapeyre‐Mestre, M., Micallef, J., & The French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP‐A) Working Group on Cannabis Complications*
- Venue
- Journal of the American Heart Association
- Published
- 2014-03-24
- Volume
- 3
- Issue
- 2
- Pages
- e000638-e000638
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2036864753
- Cited by
- 253
- References
- 37
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.